- Home
- ANEB vs COCH Comparison
ANEB vs COCH Comparison
Compare ANEB & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- COCH
- Stock Information
- Founded
- ANEB 2020
- COCH 1995
- Country
- ANEB United States
- COCH United States
- Employees
- ANEB N/A
- COCH N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- ANEB Health Care
- COCH Finance
- Exchange
- ANEB Nasdaq
- COCH Nasdaq
- Market Cap
- ANEB 39.0M
- COCH 31.6M
- IPO Year
- ANEB 2021
- COCH N/A
- Fundamental
- Price
- ANEB $1.66
- COCH $1.47
- Analyst Decision
- ANEB Strong Buy
- COCH Strong Buy
- Analyst Count
- ANEB 2
- COCH 2
- Target Price
- ANEB $5.50
- COCH $9.25
- AVG Volume (30 Days)
- ANEB 21.1K
- COCH 25.8K
- Earning Date
- ANEB 05-13-2025
- COCH 08-11-2025
- Dividend Yield
- ANEB N/A
- COCH N/A
- EPS Growth
- ANEB N/A
- COCH N/A
- EPS
- ANEB N/A
- COCH N/A
- Revenue
- ANEB N/A
- COCH $212,000.00
- Revenue This Year
- ANEB N/A
- COCH $8.04
- Revenue Next Year
- ANEB N/A
- COCH $15.39
- P/E Ratio
- ANEB N/A
- COCH N/A
- Revenue Growth
- ANEB N/A
- COCH N/A
- 52 Week Low
- ANEB $0.80
- COCH $1.21
- 52 Week High
- ANEB $3.08
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- ANEB 59.78
- COCH 48.45
- Support Level
- ANEB $1.57
- COCH $1.40
- Resistance Level
- ANEB $2.00
- COCH $1.58
- Average True Range (ATR)
- ANEB 0.25
- COCH 0.10
- MACD
- ANEB 0.00
- COCH 0.01
- Stochastic Oscillator
- ANEB 30.25
- COCH 43.74
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.